Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel Group, Dose-Ranging, Controlled, Multi-Center Study to Assess the Efficacy and Safety of Nexagon® in the Treatment of Subjects With a Venous Leg Ulcer

NCT01199588 is registered in ClinicalTrials.gov with OcuNexus Therapeutics, Inc. as lead sponsor.

NCT NCT01199588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01199588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel Group, Dose-Ranging, Controlled, Multi-Center Study to Assess the Efficacy and Safety of Nexagon® in the Treatment of Subjects With a Venous Leg Ulcer
Lead sponsor
OcuNexus Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2011
Completion date
March 31, 2013
Enrollment
300 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

venous leg ulcers